Systemic Therapy for Stage IV Melanoma: Current Standards, Questions, and Investigations

Download this slideset to gain key insights into current therapeutic strategies in advanced melanoma, including optimal approaches for managing CNS metastases.
Michael A. Davies, MD, PhD
Format: Microsoft PowerPoint (.ppt)
File Size: 681 KB
Released: November 3, 2020

Acknowledgements

Provided by Clinical Care Options, LLC

Clinical Care Options, LLC
12001 Sunrise Valley Drive
Suite 300
Reston, VA

Sophia Kelley
(203)-316-2125
skelley@clinicaloptions.com
www.clinicaloptions.com

Supported by educational grants from
Bristol-Myers Squibb
Novartis Pharmaceuticals Corporation

Related Content

Expert commentary from Allison Betof Warner, MD, PhD, on selecting optimal frontline therapy for metastatic melanoma, from Clinical Care Options (CCO)

person default Allison Betof Warner, MD, PhD Released: February 17, 2021

Gain key clinical insights fast, with this short slideset from CCO on therapy for high-risk, resectable melanoma and metastatic melanoma.

Michael A. Davies, MD, PhD Ahmad Tarhini, MD, PhD Released: November 6, 2020

In this slideset from Clinical Care Options (CCO), Ahmad A. Tarhini, MD, PhD offers insight on optimizing adjuvant therapy for high-risk melanoma

Ahmad Tarhini, MD, PhD Released: November 3, 2020

Expert-authored commentary from Clinical Care Options (CCO) on factors to consider when using adjuvant targeted therapy for high-risk resected melanoma with BRAF mutations

Douglas B. Johnson, MD, MSCI Released: October 19, 2020

Leaving the CCO site

You are now leaving the CCO site. The new destination site may have different terms of use and privacy policy.

Continue